HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    


Top Stocks Set to Outperform
Over the Next 1 to 3 Months.

Click for your free picks >>

Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Top 10 Stocks
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive

ENDP: Endo Pharmaceutical Hldgs - Stock News Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Company News |  Zacks Commentary
ENDO PHARMACEUTICAL HLDGS (NASD)
ENDP 22.75 0.55 (2.48%) Vol.  1,053,382 16.00 CST

Nov 20, 2009 Endo Pharmaceuticals (ENDP) Trading On Heavy Volume
Nov 17, 2009 TXRH, SEIC, ENDP, ADCT, CBAK and AONE Receives Analytical Coveragefrom WallStSense.com
Nov 17, 2009 LecTec and Endo Pharmaceuticals Come to Terms on Patent Dispute
Nov 12, 2009 LecTec reaches settlement with Endo Pharmaceuticals Inc over patent dispute
Nov 12, 2009 Stockguru.com: Lectec Corp. is in the StockGuru Spotlight for November 12, 2009
Nov 11, 2009 LecTec Corporation and Endo Pharmaceuticals Inc. Settle Patent Dispute
Nov 11, 2009 Endo Pharmaceuticals and LecTec Settle Patent Dispute
Nov 06, 2009 RXi Pharmaceuticals Appoints Noah D. Beerman as CEO
Nov 06, 2009 Bioniche Reports Fiscal 2010 First Quarter Results And Achievement of First Milestone Under Licensing Agreement
Nov 06, 2009 TheFortuneFinancial.com Free Market Research on DLTR, FAST, AONE,FMCN, ENDP and CNXT
Oct 30, 2009 BUYINS.NET: Endo Pharmaceuticals (ENDP) Up After BUYINS.NET Report Predicted Strength After Earnings
Oct 29, 2009 Endo Pharmaceuticals Raises Guidance to be In-line with Estimates
Oct 29, 2009 Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full-Year Financial Guidance
Oct 29, 2009 Conference Calls Today: 9 A.M. EDT
Oct 28, 2009 AnalystChoice.com Initiates Research on ENDP, CTAS, AONE, NFLX, COSTand FAST
 
ZACKS COMMENTARY FOR ENDP

 
About Zacks | Advertise | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2009 Zacks Investment Research